Gemcitabine for the treatment of advanced nonsmall cell lung cancer
Luca Toschi1, Federico Cappuzzo21Dana-Farber Cancer Institute, Medical Oncology, Boston, MA, USA; 2Istituto Clinico Humanitas IRCCS, Department of Onco-Hematology, Rozzano, ItalyAbstract: Gemcitabine is a pyrimidine nucleoside antimetabolite agent which is active in several human malignancies, inclu...
Main Authors: | Luca Toschi, Federico Cappuzzo |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-08-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/gemcitabine-for-the-treatment-of-advanced-nonsmall-cell-lung-cancer-a3405 |
Similar Items
-
First-Line Gemcitabine Plus Cisplatin in Nonsmall Cell Lung Cancer Patients
by: Ying Li, et al.
Published: (2014-01-01) -
Targeted Therapies Development in the Treatment of Advanced Nonsmall Cell Lung Cancer
by: Cesare Gridelli, et al.
Published: (2011-01-01) -
Nonsmall cell lung cancer
by: Jean-Paul Sculier
Published: (2013-03-01) -
Importance of dose intensity in treatment of advanced nonsmall cell lung cancer in the elderly
by: Narayanan Prasad, et al.
Published: (2012-07-01) -
Bronchoscopic treatment of inoperable nonsmall cell lung cancer
by: Christopher M. Kniese, et al.
Published: (2020-11-01)